Dominic E Dwyer Selected Research

Nucleic Acids

4/2022	Influenza epidemiology in patients admitted to sentinel Australian hospitals in 2019: the Influenza Complications Alert Network (FluCAN).
3/2022	Surveillance for severe influenza and COVID-19 in patients admitted to sentinel Australian hospitals in 2020: the Influenza Complications Alert Network (FluCAN).
12/2021	The utility of SARS-CoV-2-specific serology in COVID-19 diagnosis.
9/2020	The Antibody Response to SARS-CoV-2 Infection.
11/2019	Influenza epidemiology in patients admitted to sentinel Australian hospitals in 2018: the Influenza Complications Alert Network (FluCAN).
1/2019	Influenza epidemiology in patients admitted to sentinel Australian hospitals in 2017: the Influenza Complications Alert Network (FluCAN).
1/2018	Point-of-care diagnostics for respiratory viral infections.
12/2016	Influenza epidemiology in patients admitted to sentinel Australian hospitals in 2015: the Influenza Complications Alert Network.
9/2015	Influenza epidemiology in adults admitted to sentinel Australian hospitals in 2014: the Influenza Complications Alert Network (FluCAN).
9/2015	What assay is optimal for the diagnosis of measles virus infection? An evaluation of the performance of a measles virus real-time reverse transcriptase PCR using the Cepheid SmartCycler(®) and antigen detection by immunofluorescence.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dominic E Dwyer Research Topics

Disease

43	Human Influenza (Influenza) 04/2022 - 01/2004
23	Infections 01/2022 - 09/2002
8	COVID-19 03/2022 - 09/2020
6	Disease Progression 01/2022 - 06/2004
5	Measles 01/2018 - 01/2006
4	Viremia 01/2022 - 07/2005
4	Coinfection 01/2022 - 02/2004
4	Herpes Zoster 12/2020 - 09/2002
4	Chickenpox 08/2013 - 09/2002
2	Communicable Diseases (Infectious Diseases) 12/2021 - 08/2009
2	Pain (Aches) 01/2019 - 09/2002
2	Demyelinating Diseases (Demyelinating Disease) 08/2013 - 01/2012
2	Pneumonia (Pneumonitis) 01/2013 - 07/2007
2	Inflammation (Inflammations) 01/2013 - 01/2013
2	HIV Infections (HIV Infection) 03/2010 - 02/2004
1	Reinfection 01/2022
1	Mumps 08/2020
1	Parotitis (Parotiditis) 08/2020
1	Coronavirus Infections 07/2020
1	Meningoencephalitis 02/2020
1	Poliomyelitis (Polio) 01/2020
1	Chronic Hepatitis C 01/2019
1	Fatigue 01/2019
1	Rubella (German Measles) 11/2018
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2018
1	Exanthema (Rash) 04/2015
1	Epstein-Barr Virus Infections 04/2015
1	Common Cold 01/2014
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2013
1	Multiple Sclerosis 06/2012
1	Anemia 01/2012
1	Virus Diseases (Viral Diseases) 05/2011
1	Vomiting 01/2011
1	Infectious Mononucleosis (Glandular Fever) 09/2010
1	Orthomyxoviridae Infections 08/2009
1	Injection Site Reaction 01/2008
1	Lymphopenia (Lymphocytopenia) 11/2005
1	Latent Infection 07/2005
1	Severe Acute Respiratory Syndrome 07/2004
1	Drug-Related Side Effects and Adverse Reactions 06/2004
1	Postherpetic Neuralgia 09/2002
1	Herpes Genitalis (Genital Herpes) 09/2002

Drug/Important Bio-Agent (IBA)

20	VaccinesIBA 01/2022 - 01/2006
17	Antiviral Agents (Antivirals)IBA 12/2020 - 09/2002
16	Nucleic AcidsIBA 04/2022 - 09/2002
8	AntigensIBA 01/2022 - 09/2002
8	AntibodiesIBA 01/2021 - 09/2002
8	Oseltamivir (Tamiflu)FDA Link 02/2013 - 01/2009
7	Immunoglobulin G (IgG)IBA 09/2020 - 06/2012
6	RNA (Ribonucleic Acid)IBA 01/2022 - 03/2010
6	DNA (Deoxyribonucleic Acid)IBA 08/2013 - 07/2005
6	Neuraminidase (Sialidase)IBA 02/2013 - 11/2006
4	Anti-Bacterial Agents (Antibiotics)IBA 04/2015 - 03/2013
4	Influenza Vaccines (Influenza Vaccine)FDA Link 06/2014 - 01/2004
3	Pharmaceutical PreparationsIBA 01/2022 - 06/2004
3	EnzymesIBA 08/2020 - 01/2018
2	N-acetyltalosaminuronic acid (NAT)IBA 12/2021 - 09/2020
2	CytokinesIBA 01/2013 - 11/2005
1	Broadly Neutralizing AntibodiesIBA 01/2022
1	N-(2-cyanoethylene)urea (BA 1)IBA 01/2022
1	Complementary DNA (cDNA)IBA 12/2021
1	Nucleocapsid ProteinsIBA 01/2021
1	Herpes Zoster VaccineIBA 12/2020
1	Attenuated VaccinesIBA 12/2020
1	Immunoglobulin A (IgA)IBA 09/2020
1	Immunoglobulin M (IgM)IBA 09/2020
1	B 31IBA 01/2019
1	P-30 composite resin (P 30)IBA 01/2017
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 09/2015
1	PlasticsIBA 04/2014
1	Stainless Steel (Steel, Stainless)IBA 04/2014
1	Pertussis ToxinIBA 01/2014
1	Chickenpox Vaccine (Vaccine, Varicella)IBA 05/2013
1	Subunit VaccinesIBA 04/2013
1	Glycoproteins (Glycoprotein)IBA 04/2013
1	AdamantaneIBA 02/2013
1	Zanamivir (Relenza)FDA Link 02/2013
1	ORALIT (ORS)IBA 01/2013
1	Biomarkers (Surrogate Marker)IBA 01/2013
1	AllergensIBA 01/2012
1	OligonucleotidesIBA 08/2011
1	Immunoglobulins (Immunoglobulin)IBA 05/2009
1	Coloring Agents (Dyes)IBA 09/2008
1	Enfuvirtide (Fuzeon)FDA Link 01/2008
1	Surface Antigens (Surface Antigen)IBA 11/2007
1	Neutralizing AntibodiesIBA 09/2007
1	Complement System Proteins (Complement)IBA 07/2007
1	Anti-Infective Agents (Microbicides)IBA 02/2004

Therapy/Procedure

8	Therapeutics 01/2022 - 09/2002
5	Mechanical Ventilators (Ventilator) 07/2020 - 07/2009
5	Highly Active Antiretroviral Therapy (HAART) 11/2007 - 01/2003
2	N95 Respirators 05/2014 - 05/2011
1	Art Therapy 01/2022
1	Incubators 01/2022
1	Hand Hygiene 04/2014
1	Ambulatory Care (Outpatient Care) 01/2013
1	Long-Term Care 01/2009
1	Personal Protective Equipment 10/2007